Abstract
Objective: To delimit the neurological manifestations caused by infection by Sars-Cov-, 2 virus that causes COVID-19. Bibliographic review: SARS-CoV-2 is a virus predominantly related to clinical manifestations in the respiratory system, but currently displays consistent evidence that points to the involvement of the nervous system, showing a neurotropism. The most frequently reported neurological symptoms are: headache, anosmia, ageusia and occurrence of cerebrovascular events (CVA). In addition, SARS-CoV-2 infection has also been linked as a risk factor for the occurrence of Alzheimer's disease, Guillain Barré syndrome, headache, encephalitis, changes in levels of consciousness and also the presence of peripheral facial paralysis. It is believed that patients with pre-existing neurological impairment are more likely to develop nerve complications as a result of SARS-Cov-2 infection. Final considerations: COVID-19 can cause a range of neurological diseases. It is necessary to carry out studies on the topic in order to better clarify the findings and clinical conduct to be adopted.